FCX vs TERN · P/E 38, rev $25.45B vs $6.12B cap
Freeport-McMoran Copper & Gold Inc (FCX) versus Terns Pharmaceuticals Inc (TERN) — a side-by-side from cached financials, not a winner call.
Freeport-McMoran Copper & Gold Inc (FCX) is a copper company listed on US.
Terns Pharmaceuticals Inc (TERN) is a biotechnology company listed on NASDAQ.
Latest reported FCX revenue for 2024-12-31 was $25.45B. Net income was $4.40B. Revenue was up 11.4% from 2023-12-31 to 2024-12-31. FCX currently screens at market cap $67.80B and trailing P/E 38.0.
Latest reported TERN revenue for 2022-12-31 was $0. Net income was -$60.3M. TERN currently screens at market cap $6.12B.
FCX currently screens at market cap $67.80B and trailing P/E 38.0. TERN currently screens at market cap $6.12B.
Not investment advice. Open the FCX and TERN stock pages for the full models.
Not investment advice.